Skip to main content
SpringerLink
Log in

RE: Letter to the Editor “Practical Issues with Using Direct Oral Anticoagulant After Bariatric Metabolic Surgery” Following the Publication of: “30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents PMVT Following Laparoscopic Sleeve Gastrectomy”

  • Letter to Editor/LED Reply
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

Data available upon request.

References

  1. Swartz DE, Hood L, Swartz DR, et al. 30-day post-discharge prophylaxis with rivaroxaban prevents porto-mesenteric venous thrombosis following laparoscopic sleeve gastrectomy. Obes Surg. 2023;3(4):1026–31.

    Article  Google Scholar 

  2. Nasser MF, Jabri A, Gandhi S, et al. Oral anticoagulant use in morbid obesity and post bariatric surgery: a review. Am J Med. 2021;134(12):1465-75.

  3. Rosovsky RP, Kline-Rogers E, Lake L, et al. Direct oral anticoagulants in obest patients with venous thromboembolism: results of an expert consensus panel. Am J Med. 2023.

  4. Martin KA, Lee CR, Farrell TM, et al. Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance. Am J Med. 2017;130(5):517–24.

    Article  CAS  PubMed  Google Scholar 

  5. Aminian A, Vosburg RW, Altiere MS, et al. American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolic prophylaxis in bariatric surgery. Surg Obes Relat Dis. 2022;18(2):165–74.

    Article  PubMed  Google Scholar 

  6. Hany M, Abouelnasr AA, Agayby ASS, et al. Towards zero thromboembolic events after bariatric metabolic surgery. Obes Surg. 2023.

Download references

Author information

Authors and Affiliations

  1. Saint Agnes Care Metabolic and Bariatric Surgery, Saint Agnes Medical Center, 1510 East Herndon Ave., Ste 210, Fresno, CA, 93720, USA

    Daniel E. Swartz

  2. California Cancer Associates for Research & Excellence, 7130 N Millbrook Ave, Fresno, CA, 93720, USA

    Sachin Gupta

Authors
  1. Daniel E. Swartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sachin Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel E. Swartz.

Ethics declarations

Conflict of Interest

Daniel E. Swartz, MD, is a consultant for Intuitive Surgical, Inc. and receives employer-supported CME reimbursement to attend symposia. Sachin Gupta, MD, has no disclosures/conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Swartz, D.E., Gupta, S. RE: Letter to the Editor “Practical Issues with Using Direct Oral Anticoagulant After Bariatric Metabolic Surgery” Following the Publication of: “30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents PMVT Following Laparoscopic Sleeve Gastrectomy”. OBES SURG 33, 1930–1931 (2023). https://doi.org/10.1007/s11695-023-06592-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-023-06592-5

Keywords

Search

Navigation